The Journal of Immunology, Vol 145, Issue 1 209-214, Copyright © 1990 by American Association of Immunologists

ARTICLES

The complement SC5b-9 complex mediates cell adhesion through a vitronectin receptor

G Biesecker
Department of Pathology, Hahnemann University, Philadelphia, PA 19102.

Adhesion of cells to the terminal complement complex of C5b through C9 containing the serum S-protein (SC5b-9) was investigated using a microtiter plate attachment assay with L8 myoblast indicator cells. The skeletal muscle-derived L8 myoblasts bound and spread on substratum coated with SC5b-9, and with the vitronectin/S-protein component of SC5b-9. The myoblasts did not adhere to substratum coated with collagen, laminin, or fibronectin. The cell attachment was blocked by antibody to vitronectin/S-protein, whereas antibody to the other components C5, C6, C7, C8, or C9 had minimal effect. The cells were not bound to free vitronectin because attachment activity was removed by adsorption with an anti-C6 antibody column. The L8 cell attachment was dependent on divalent cations, was blocked by synthetic peptides containing the amino acid sequence Arg-Gly-Asp, and was inhibited by antivitronectin receptor antibody. These results indicate that cells adhere to the SC5b-9 complex through interaction of the vitronectin component with an integrin vitronectin receptor. Cell attachment to terminal C complexes could be used for leukocyte adherence and migration during inflammation, and also for attachment of tissue cells during regeneration after disease or traumatic injury.

This article has been cited by other articles:

				F. Bossi, F. Fischetti, V. Pellis, R. Bulla, E. Ferrero, T. E. Mollnes, D. Regoli, and F. Tedesco Platelet-Activating Factor and Kinin-Dependent Vascular Leakage as a Novel Functional Activity of the Soluble Terminal Complement Complex J. Immunol., December 1, 2004; 173(11): 6921 - 6927. [Abstract] [Full Text] [PDF]

				P. Aukrust, L. Gullestad, K. T. Lappegard, T. Ueland, H. Aass, L. Wikeby, S. Simonsen, S. S. Froland, and T. E. Mollnes Complement Activation in Patients With Congestive Heart Failure: Effect of High-Dose Intravenous Immunoglobulin Treatment Circulation, September 25, 2001; 104(13): 1494 - 1500. [Abstract] [Full Text] [PDF]

				N. Rinaldi, D Weis, B Brado, M Schwarz-Eywill, M Lukoschek, A Pezzutto, U Keilholz, and T F E Barth Differential expression and functional behaviour of the alpha v and beta 3 integrin subunits in cytokine stimulated fibroblast-like cells derived from synovial tissue of rheumatoid arthritis and osteoarthritis in vitro Ann Rheum Dis, December 1, 1997; 56(12): 729 - 736. [Abstract] [Full Text] [PDF]

				H. Tsukada, X. Ying, C. Fu, S. Ishikawa, P. McKeown-Longo, S. Albelda, S. Bhattacharya, B. A. Bray, and J. Bhattacharya Ligation of Endothelial {alpha}vß3 Integrin Increases Capillary Hydraulic Conductivity of Rat Lung Circ. Res., October 1, 1995; 77(4): 651 - 659. [Abstract] [Full Text]

				S. Bhattacharya, C. Fu, J. Bhattacharya, and S. Greenberg Soluble Ligands of the [IMAGE][IMAGE][IMAGE][IMAGE] Integrin Mediate Enhanced Tyrosine Phosphorylation of Multiple Proteins in Adherent Bovine Pulmonary Artery Endothelial Cells J. Biol. Chem., July 14, 1995; 270(28): 16781 - 16787. [Abstract] [Full Text] [PDF]